FP85
690
Dr.Suresha A R
| Membership No | Author Name | Mobile | |
|---|---|---|---|
| 4250MW | Dr.SREE VARNA M | msv186999@gmail.com | 9108460246 |
Glaucoma
Inhaled Corticosteroid Therapy and Intraocular Pressure: A Prospective 6-Month Study
Purpose: To evaluate the 6-month effect of newly initiated inhaled corticosteroid (ICS) therapy on intraocular pressure (IOP). Methods: A prospective observational study included 70 patients (20–80 years) started on inhaled budesonide or fluticasone. Patients with glaucoma, ocular trauma, uveitis, prior ocular surgery, or topical steroid use were excluded. Baseline ophthalmic examination and monthly IOP measurements for 6 months were performed using GAT . Data were analyzed using repeated-measures ANOVA. Results: Mean IOP increased significantly over 6 months (p<0.05). IOP rose by <2 mmHg in 27 patients, 2–4 mmHg in 31, 4–6 mmHg in 9, and ≥6 mmHg in 3. Budesonide users had slightly higher IOP than fluticasone users, but the difference was not significant (p>0.05). No patient had IOP >21 mmHg. Conclusion: ICS therapy caused a mild but significant rise in IOP which remained within normal limits. Regular ophthalmic monitoring is recommended in patients at risk for glaucoma
No Co-Author Selected